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Abstract-Ionizing radiation is a well-established cause of thyroid cancer and nodular- 
ity, however, important questions relating to the magnitude of the risk following 
low-dose medical exposures remain unresolved. To address these issues, we conducted 
a follow-up study of 1590 individuals treated between 1938 and 1969 with X-rays for 
childhood lymphoid hyperplasia (av. thyroid dose = 24 cGy) and 1499 individuals 
treated with surgery only. Thyroid nodularity was determined from self-administered 
questionnaires completed by 1195 irradiated and 1063 surgically-treated subjects and 
from clinical examinations of 602 irradiated and 457 non-irradiated subjects. A much 
higher relative risk (RR) for radiation-induced thyroid nodules was estimated from the 
questionnaire than from the clinical examination data, 15.8 and 2.7, respectively. (The 
corresponding estimates of excess RR per cGy were 64 and 7%). Analysis of the 
examination data revealed a strong dose-response relationship, similar excess RR/cGy 
for males and females, and an inverse relationship with age at exposure. Although the 
thyroid gland is one of the most sensitive organs to the neoplastic effects of radiation, 
the radiation-induced risk of thyroid nodularity reported from questionnaire studies 
may over-estimate the true risk. 
Thyroid gland Thyroid nodularity 
Lymphoid hyperplasia Dose-response 
Ionizing radiation Risk Cohort 
INTRODUCTION 
The thyroid gland is highly sensitive to the 
tumorigenic effects of ionizing radiation. Indi- 
viduals irradiated in childhood for thymic en- 
largement [1, 21, tinea capitis [3-51, and a variety 
of other benign head and neck conditions [&lo] 
*All correspondence should be addressed to: Dr L. M. 
Pottern, National Cancer Institute, Epidemiology and 
Biostatistics Program, Executive Plaza North, Room 
418. Bethesda, MD 20892, U.S.A. 
are at increased risk for thyroid cancer or 
nodules after a sufficient length of time has 
elapsed. Excess thyroid neoplasms have also 
been observed among atomic bomb survivors 
[I l] and among Marshallese Islanders acciden- 
tally exposed to radioactive fallout [12, 131, al- 
though patients given diagnostic doses of 
radioactive iodine [14] have not shown an ex- 
cess. Despite these numerous studies, important 
questions remain as to the magnitude of the risk 
of thyroid tumors following low-dose medical 
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X-irradiation. Problems with existing estimates 
of risk include imprecise assessment of the dose 
to the thyroid gland, under-diagnosis of thyroid 
tumors, over-aggressive clinical detection of 
“occult” or indolent cancers among irradiated 
individuals, and the absence of appropriate 
comparison groups. 
A historical prospective study was designed to 
overcome the limitations of previously con- 
ducted studies and to evaluate more accurately 
the risk of thyroid tumors and other clinical 
outcomes due to childhood X-irradiation for 
lymphoid hyperplasia, primarily enlarged ton- 
sils or adenoids. A cohort of individuals who 
received radiotherapy for lymphoid hyperplasia 
and a non-irradiated comparison group who 
received only surgical treatment at the Chil- 
dren’s Hospital Medical Center (CHMC) in 
Boston, Massachusetts comprised the study 
population. The availability of detailed radio- 
therapy records on virtually all the irradiated 
subjects enabled the reconstruction of the 
radiation dose to the thyroid gland for each 
individual. 
Unlike previously conducted studies of irradi- 
ated populations, the present study included 
both a questionnaire and a clinical examination 
component for the exposed and non-exposed 
subjects. This design allowed for evaluation of 
(1) the risk of radiation-induced thyroid cancer, 
thyroid nodules and other head and neck condi- 
tions based on questionnaire data; (2) the risk of 
radiation-induced palpable thyroid nodules 
and thyroid dysfunction based on clinical ex- 
aminations; and (3) the direct comparison of 
risks obtained from these two different methods 
of tumor ascertainment. 
This paper contrasts the findings of radiation- 
induced thyroid nodularity determined from 
questionnaire and clinical examination data and 
explores the modifying effects of host factors 
such as age at exposure, gender and Jewish 
ethnicity on the radiogenic risk of palpable 
thyroid nodules. 
METHODS 
IdentiJication of cohort 
The study cohort consisted of individuals 
treated prior to age 18 with X-rays or surgery 
for lymphoid hyperplasia at CHMC during the 
years 1938-1969. The majority of the radiation 
treatments, 97%, were for enlarged tonsils or 
adenoids. Figure 1 presents the number of sub- 
jects included in each step and phase of the 
study. 
All individuals who received X-ray treatment 
for lymphoid hyperplasia (exposed group) were 
identified from radiotherapy index cards filed by 
diagnosis and located in the Radiation Therapy 
Department at CHMC. Prior to the start of this 
study, it was known that this index file included 
patients who were irradiated for lymphoid 
hyperplasia because researchers at CHMC and 
Harvard Medical School [ 151 conducted a ques- 
tionnaire survey of the parents of these patients 
Exposed Non-Exposed 
Major Steps: 
11 Initial Study Population: 
2) Located During Tracing: 
31 Responded to Questionnaire: 
4) Eligible for Examination Phase: 
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Fig. 1. Number of subjects included in each step of the study by exposure status. 
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in 1958 to assess the effectiveness of such radia- 
tion treatments. 
Exposed subjects were excluded from the 
study cohort if their medical records revealed 
that they (1) died or developed a thyroid disease 
or cancer prior to or within 1 year after their 
first radiation treatment at CHMC or (2) re- 
ceived other radiotherapy to the head or neck 
for a condition other than lymphoid hyper- 
plasia. The exposed cohort consisted of 1590 
(970 male and 620 female) X-irradiated subjects 
(see Fig. 1; step 1). 
Surgical index cards located in the Medical 
Records Department at CHMC were used to 
identify all individuals who had a tonsillectomy 
and/or adenoidectomy for treatment of lymph- 
oid hyperplasia. A stratified random sample 
of these non-irradiated surgically-treated indi- 
viduals (non-exposed group) was then selected 
based on the gender, age and year of treatment 
distribution of the exposed population. Non- 
exposed subjects were excluded from the study 
cohort if their medical records indicated that 
they (1) died or developed thyroid disease or 
any cancer prior to or within 1 year of their 
head and neck surgery at CHMC or (2) re- 
ceived any radiation therapy to the head or 
neck region. A total of 1499 (905 male and 
594 female) surgically-treated individuals com- 
prised the non-exposed cohort (see Fig. 1; 
step 1). 
Medical record abstraction 
Medical records were abstracted for demo- 
graphic characteristics, past medical history and 
information that could provide leads for lo- 
cating the subjects. An indepth review of a 
sample of records was undertaken to determine 
whether the referring physician or radiologist 
indicated why the lymphoid hyperplasia patient 
was chosen to have radiotherapy rather than 
surgery. This review did not indicate any specific 
selection criteria for a particular treatment. 
Patients who underwent radiotherapy did not 
appear to have any contraindications for 
surgery, in fact, the majority of them had tonsil- 
lectomies at a later date. The records of the 
surgically-treated only patients did not state any 
reason why surgery was chosen over radio- 
therapy. A pediatric radiotherapist who treated 
many of the patients in the early years informed 
us that radiation therapy for lymphoid hyper- 
plasia was a common and relatively simple 
mode of treatment back in the early 1940s and 
1950s and that it was at the discretion of the 
physician to select the appropriate type of treat- 
ment. To his knowledge, there were no estab- 
lished criteria for choosing one therapy over 
another. 
Radiation dosimetry 
CHMC radiation treatment records of ex- 
posed subjects were retrieved and abstracted for 
the following information: reason for irradia- 
tion, age at treatment, dates of treatments, 
regions irradiated, air doses and radiation field 
sizes, The nasopharyngeal region was the typical 
site for the X-ray treatments. The majority of 
the subjects received a left-sided and right-sided 
treatment to the neck or face on the same day. 
This procedure would typically be repeated a 
week later. The average cumulative air dose 
of radiation received was 800 R. The most 
common irradiation field sizes were 6 x 8 cm, 
5 x 7 cm and 6 x 7 cm. Dose to the thyroid for 
each individual in the study was determined 
using treatment details abstracted from the 
radiotherapy record and the measurements de- 
scribed below. Measurements of radiation ab- 
sorbed dose were made in an anthropomorphic 
phantom, the size of a 6-year-old child, com- 
posed of three tissues; real skeleton and simu- 
lated lung and muscle. Treatments were 
simulated using 6 x 7 cm lateral fields located 
on the nasopharynx. The phantom was irradi- 
ated using a Philips RT250 orthovoltage 
machine. Measurements were made at two 
different X-ray energies, 3.0 mm Cu half-value 
layer (HVL) and 1.2 mm Cu HVL. Thermo- 
luminescent dosimeters (TLD) were placed 
throughout the thyroid in order to estimate 
average dose to the organ. The TLD were 
calibrated using an ionization chamber trace- 
able to the National Bureau of Standards. A 
correction factor was applied to the thyroid 
dose determined from the 6-year-old child to 
estimate dose for children of other ages. This 
factor was based on the distance from the field 
edge to the midpoint of the thyroid for children 
of various ages and measured water phantom 
data. 
In general, the thyroid doses for this study are 
subject to an uncertainty of approximately 
f50%. The Philips RT250 is typical of the 
machines used since the early 1950s but may 
differ from machines used in previous years. The 
motion of children during treatment is also an 
important consideration in dose uncertainties. 
Any movement producing a 1 cm change in 
distance from the field edge to the thyroid gland 
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results in a minimum of +30% change in the 
dose to the thyroid. In addition, all children 
were assumed to be of normal size for their 
ages. The uncertainty in the TLD system is 
f5%. 
Location methods 
Various sources (e.g. Registry of Motor Vehi- 
cles, Town Registrar’s List of Residents, Post 
Offices) were used during tracing until a valid 
address could be obtained or the subject was 
determined to be deceased. 
Eighty-seven percent of the subjects (1385 
exposed and 1286 non-exposed) were located 
(see Fig. 1; step 2). These subjects were similar 
to those not located with respect to exposure 
status, gender, treatment age, year of treatment, 
and radiation dose to the thyroid for exposed 
individuals. 
Questionnaire component 
The 2569 subjects located alive were mailed 
an explanatory letter and a questionnaire to 
complete. 90% of the exposed subjects and 86% 
of the non-exposed subjects completed the ques- 
tionnaire (see Fig. 1; step 3). At the time of 
questionnaire completion, 60% of both the ex- 
posed and non-exposed questionnaire respon- 
dents lived in Massachusetts and 14% of the 
exposed and 12% of the non-exposed subjects 
resided in other New England states (i.e. Rhode 
Island, Connecticut, Maine, Vermont, New 
Hampshire). 
The questionnaire included information on: 
sociodemographic characteristics such as gen- 
der, birthdate, religion, education and usual 
occupation; medical history of thyroid disorders 
and cancer, thyroid medication use, head and 
neck operations and irradiation, and major 
medical conditions; and family history of 
thyroid conditions and cancer. 
The section on thyroid disorders listed 
thyroid conditions such as hypothyroidism, 
hyperthyroidism, thyroid nodules and thyroid 
cancer. The subject was asked to check yes or no 
for each condition, record the age when the 
disorder was first diagnosed and the name and 
address of the doctor (or hospital) who treated 
the condition. Validation of all cancers, benign 
tumors, goiters, thyroid nodules, non-specific 
tumors or cysts reported on the questionnaire 
was attempted by requesting pathology reports 
and/or medical records from the appropriate 
treatment facility or physician. 
Clinical examination component 
All questionnaire respondents who lived in 
the New England area and those respondents 
who checked yes on the questionnaire that they 
planned to visit the New England area were 
considered eligible to participate in the examin- 
ation component of the study (see Fig. 1; step 4). 
Cost and logistical considerations for the sub- 
jects dictated the need to place this geographic 
restriction on eligibility for examination. 
Each of the eligible subjects was sent a letter 
offering a free clinical examination, primarily of 
the head and neck region. 59% of the exposed 
and 52% of the non-exposed eligible subjects 
accepted our invitation (see Fig. 1; step 5). 
Among the questionnaire respondents who were 
from Massachusetts, 67% of the exposed and 
62% of the non-exposed subjects were ex- 
amined. 51% of the exposed and 31 O/O of the 
non-exposed respondents who lived in the other 
New England states also agreed to the clinical 
examination. Of the questionnaire respondents 
who lived outside of New England but were 
considered eligible for examination because they 
planned to visit the area, 29% of the exposed 
and 20% of the non-exposed subjects actually 
came for an examination. 
The examination sessions were held between 
November 1981 and October 1983. Subjects 
were asked to read and sign a consent form and 
complete a pre-examination questionnaire. 
The questionnaire requested current medical 
information and medication use that could 
help in interpreting the clinical examination 
and the blood test results. All subjects were 
paid U.S.$lO.OO for transportation and other 
expenses. 
Comparisons of various sociodemographic 
characteristics reported on the questionnaire 
revealed that examined subjects were similar to 
subject who were not examined with respect to 
gender, educational status, and usual occupa- 
tion. Examined and not-examined subjects also 
reported a similar history of thyroid disease. 
Among the exposed subjects, approximately 4% 
of both the examined subjects and not-examined 
subjects reported a previous diagnosis of a 
thyroid nodule or thyroid cancer. Among the 
non-exposed subjects, 1 examined subject and 2 
not-examined subjects reported a history of a 
thyroid nodule. No thyroid cancer was reported 
by any non-exposed subject. 
Prior to the head and neck examination, 
height, weight, pulse and blood pressure 
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measurements were taken by a technician. In 
addition, 20 ml of blood were drawn from con- 
senting subjects for analysis of thyroid hormone 
concentrations and related measurements. 
Each subject was examined independently by 
two of four collaborating thyroidologists who 
were unaware of the subject’s exposure status 
and medical history. Procedures used were 
similar to a recent study conducted in Boston 
of patients exposed to multiple fluoroscopic 
X-rays during tuberculosis treatments [16]. 
The examination included inspection of the 
oropharynx and palpation of the parotid 
glands, submandibular glands, cervical lymph 
node chains, and the thyroid gland. The two 
examiners then compared their results and if 
any discrepancies existed they reexamined the 
subject and tried to reach a consensus. The 
consensus findings were recorded on a standard- 
ized summary form and explained to the 
subject. 
During the design of the clinical examination 
component of the study, the hospital medical 
director, the collaborating thyroidologists and 
the epidemiologists from the National Cancer 
Institute met and discussed whether thyroid 
scintiscans should be given as a routine pro- 
cedure (i.e. screening) to all subjects undergoing 
a thyroid examination. Since the clinical signifi- 
cance of “occult” thyroid tumors detected only 
by scintiscans is not clearly understood, it was 
decided that thyroid scans should be used only 
as an aid for interpreting the palpation findings. 
A subject was recommended to have a 
pertechnetate thyroid scintiscan (free of charge) 
only if the thyroidologist detected a definite or 
uncertain palpable thyroid nodule during the 
clinical examination. The scan was not per- 
formed if the subject reported having one within 
the past 6 months, was currently taking thyroid 
hormone medication or was pregnant. Of the 86 
study subjects for whom a scintiscan was recom- 
mended, 64 had the scan. The scintiscans were 
read by the examiner who compared them with 
the recorded palpation findings with respect to 
the thyroid size and shape, and to the presence, 
location and focal or diffuse nature of scinti- 
graphic abnormalities. An uncertain palpable 
nodule was reclassified as a definite nodule if 
there was a scan abnormality in the correspond- 
ing anatomical location. After evaluation of the 
scan findings, the examiners changed the diag- 
nosis of an uncertain palpable nodule to a 
definite nodule for 11 exposed and 2 non-ex- 
posed subjects. 
The results of the head and neck examination 
were sent to the study subject and/or the sub- 
ject’s physician. Specific treatment recommen- 
dations were not suggested but a list of available 
consulting specialists was offered. Since the 
diagnosis of thyroid cancer is made primarily on 
the basis of clinical suspicion and pathological 
confirmation, it was necessary to obtain treat- 
ment follow-up information on all subjects who 
had a palpable thyroid nodule detected during 
the examination. A letter along with a treatment 
follow-up form was sent to the subject’s phys- 
ician to obtain information on the type of 
treatment the subject may have received (e.g. 
surgery or medication) and future follow-up 
plans. A pathology report was requested if the 
subject was surgically treated. 
Data analysis 
Outcome variable. Non-specific thyroid nodu- 
lar disease was the outcome variable of interest 
in the present analysis. Thyroid cancer as a 
distinct entity was not evaluated since compara- 
tive analyses between questionnaire and ex- 
amination findings of thyroid cancer were not 
possible. Clinical examinations can provide in- 
formation on the presence of palpable nodules 
but cannot differentiate between benign and 
malignant thyroid tumors. A biopsy is necessary 
to confirm a diagnosis of thyroid cancer. 
From the questionnaire data, thyroid nodu- 
larity was defined as a reported history of 
thyroid nodules or thyroid cancer. From the 
examination results, thyroid nodularity was 
defined as either the presence of a definite 
palpable thyroid nodule or a thyroidectomy 
scar (evidence of previous surgical removal 
of a thyroid tumor) at examination. Multi- 
nodular goiters were not classified as thyroid 
nodules. 
Relative risk estimation. To conduct a com- 
parative analysis of questionnaire and clinical 
examination data, it was necessary to select a 
uniform measure which would describe the oc- 
currence rate of thyroid nodularity. Prevalence 
rather than incidence was used in the analysis 
since the clinical examinations would detect 
only prevalent cases of thyroid nodules. To 
measure the strength of association between 
X-ray exposure for lymphoid hyperplasia and 
thyroid nodular disease, prevalence odds ratios, 
as an estimate of the relative risk (RR), and 
95% confidence intervals (CI) were calculated 
[17, 181. The RR was considered statistically 
significant if the confidence interval did not 
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include the value one. Adjustment for potential 
confounder variables (e.g. gender, age at treat- 
ment) was performed using stratification tech- 
niques. To determine if strata-specific RRs 
differed significantly from each other, a chi- 
square test for homogeneity across strata was 
used [17]. RRs according to dose categories 
were calculated using the non-exposed subjects 
(i.e. zero exposure) as the referent group. 
Dose-response models. To assess dose- 
response, variants of the usual logistic regres- 
sion model was modified and fit to the data. The 
odds of thyroid nodular disease for dose d is 
represented by the following model: 
P(D = 1 ]d)/P(D = Old) = exp(a)R(d) (1) 
where D = 1 denotes diseased and D = 0 de- 
notes disease-free individuals, R(d) is the rela- 
tive odds in dose d, and exp(cc) represents the 
effect of variables other than dose on the odds 
of disease. At baseline exposure, i.e. zero dose, 
R(0) = 1 so that the odds of thyroid nodules 
for the non-exposed subjects are exp(u)R(O) = 
exp(cr). If R has an exponential form 
[R(d) = exp@d)], then model (1) is the usual 
logistic regression model. Our analysis indicated 
that the relative odds were best characterized by 
a linear dose-response function, that is, 
R(d)= 1 +fld (2) 
where d is the continuous dose in cGy and where 
p is the linear slope parameter, interpretable as 
the excess RR per unit increase in dose. Other 
dose-response models, such as the linear expo- 
nential [R(d) = (1 + fld)exp( - zd)] and the 
linear quadratic [R(d) = 1 + /Id + zd’)], did not 
fit the data significantly better than model (2). 
To assess whether R(d) varied by any of our 
stratifying variables (e.g. age at treatment, year 
of treatment or gender), model (2) was modified 
to include these variables as follows; 
R(d, x) = 1 + Pjd (3) 
where x, the stratifying variable, was divided 
into J categories and where pj is the excess 
RR/cGy within thejth category. To account for 
differences in the odds of thyroid nodular dis- 
ease due to factors distinct from radiation dose, 
i.e. gender (g) (with g = 1 denoting females and 
g = 0 denoting males), year of treatment (y), 
and age at treatment (a), we incorporated separ- 
ate parameters into model (1) as follows: 
exp(u + Bg + $~y + ra)R(d) (4) 
where 6, 4, r are unknown parameters and 
where the dose effect is again given by model (2) 
or model (3). Since Jewish ethnicity has been 
suggested as a risk factor for thyroid tumors, we 
also added religion (Jewish and other) into 
model (4) as a main effect and a modifier of 
dose, but neither effect was significant. To test 
whether strata-specific excess odds ratios 
differed significantly from each other, a chi- 
square test of homogeneity with J - 1 df was 
calculated by taking twice the difference be- 
tween the maximum log-likelihoods of models 
(2) and (3). 
RESULTS 
General characteristics of study participants 
The characteristics of the questionnaire re- 
spondents and examined subjects by exposure 
status are shown in Table 1. For both the 
questionnaire respondents and examined sub- 
jects, there were no statistically significant 
differences between the exposed and non- 
exposed groups for any of the sociodemo- 
graphic variables thought to be related to either 
exposure or disease outcome (i.e. gender, race, 
religion, education, occupation). Both exposed 
and non-exposed subjects were highly educated 
with over 77% having attended college and 
more than 45% reporting a usual occupation in 
the managerial or professional category. Ex- 
posed subjects were slightly older than non- 
exposed subjects at time of treatment (i.e. X-ray 
or surgery). The average years of follow-up were 
29 for all subjects with a maximum length of 44 
and 47 years for exposed and non-exposed 
subjects, respectively. For the exposed subjects, 
the mean thyroid dose was 24 cGy. 
Comparative risk estimates for thyroid nodular 
disease 
Table 2 presents the RRs and percent distri- 
bution of thyroid nodular disease calculated 
from questionnaire data and examination data. 
Among the exposed subjects, 4.3% of the ques- 
tionnaire respondents reported a history of 
thyroid nodularity, whereas 10.3% of the ex- 
amined subjects had a palpable thyroid nodule 
or a thyroidectomy scar. Among the non- 
exposed subjects, 0.3% of the questionnaire 
respondents reported thyroid nodules, while in 
contrast, 4.2% of the exam participants had a 
palpable thyroid nodule or a thyroidectomy 
scar. The radiation-induced RR of thyroid 
nodularity calculated from questionnaire data 
Thyroid Nodularity after Irradiation 455 






Marital status: married 
Usual occupation: managerial/professional 
Year of treatment 
Year of birth 
Age at treatment (yr) 
Age at follow-up (yr) 
Years of follow-up 
Thyroid dose (cGy) 
Questionnaire respondents Examined participants 
Exposed Non-exposed Exposed Non-exposed 
(n = 1195) (n = 1063) (n = 602) (n =457) 
Number of subjects (%) 
465 (38.9) 432 (40.6) 223 (37.0) 187 (40.9) 
1166 (97.6) 1037 (97.6) 587 (97.5) 449 (98.3) 
144 (12.1) 155 (14.6) 82 (13.6) 69 (15.1) 
940 (78.7) 863 (81.2) 465 (77.2) 328 (80.5) 
778 (65.1) 717 (67.5) 390 (64.8) 322 (70.5) 
546 (45.7) 515 (48.5) 269 (44.7) 215 (47.1) 
Mean + SD 
1952.7 & 5.2 
(1938-69) 
1945.8 k 5.7 
(192Wl) 
6.9 + 2.8 
(0.417.3) 
36.0 + 5.8 
(21.&56.0) 
29.1 + 5.3 
(12.W.O) 
24.1 + 6.6 
(3.2-55.0) 
(range) 
1952.8 + 4.3 1952.8 + 5.1 
(193546) (1938-68) 
1946.5 + 4.5 
(192945) 
6.2 + 2.7 
(0.4-16.0) 
35.7 f 4.5 
(17.0-53.0) 
29.4 + 4.3 
(16.W7.0) 
1945.9 + 5.j 
(192&61) 
6.9 + 2.8 
(0.4-16.0) 
35.7 f 5.5 
(21 S56.0) 
28.8 _t 5.2 
(12.S44.0) 
24.2 & 6.6 
(3S53.0) 
1952.9 k 4.3 
(1937-64) 
1946.4 i 4.3 
(1931-60) 
6.4 + 2.8 
(0.416.0) 
35.7 + 4.4 
(23.0-52.0) 
29.2 & 4.3 
(18.WI6.0) 
(RR = 15.8) was almost six times greater than 
the RR calculated from the examination data 
(RR = 2.7). 
Among the 51 exposed questionnaire respon- 
dents who reported a history of thyroid nodular 
disease, 11 had a history of surgical removal of 
thyroid cancer, four of which had a simul- 
taneous diagnosis of thyroid cancer and thyroid 
nodule at time of surgery. Of the remaining 40 
exposed subjects who reported having thyroid 
nodules, 27 had surgical removal of the nodule, 
8 were given thyroid medication only, 3 received 
no treatment and 2 did not report the type of 
treatment. No non-exposed subject reported a 
history of thyroid cancer. Of the 3 non-exposed 
subjects with a history of thyroid nodules, 2 had 
surgical removal and 1 had no treatment. 
For the 41 exposed subjects who had a palp- 
able thyroid nodule detected during the clinical 
examination (excluding the 21 subjects with a 
thyroidectomy scar), it was determined through 
contacts with the subjects’ physicians that 11 
underwent surgery within 1 year of detection. 
Two of these individuals had pathological con- 
firmation of thyroid cancer; papillary and mixed 
papillary-follicular carcinoma. Among the 17 
non-exposed subjects found to have a thyroid 
nodule during palpation (excluding the 2 sub- 
jects with a thyroidectomy scar), 5 had subse- 
quent surgical treatment. Two of these subjects 
had thyroid cancer; papillary and mixed papil- 
lary-follicular carcinoma. 
Dose-response relationship 
An increase in the RR for thyroid nodular 
disease was seen with increasing radiation dose 
to the thyroid for both questionnaire respon- 
dents and examined subjects (Table 3). The 
Table 2. Relative risks (RR) of thyroid nodular disease associated with prior radiotherapy based on questionnaire and 
clinical examination data 
Questionnaire data Examination data* 
Exposedt, $ Non-exposed4 Exposed Non-exposed 
n = 1192 II = 1063 n = 602 n = 457 
No. (%) No. (%) RR (95% CI) No. (%) No. (%) RR (95% CI) 
Nodular disease 
No 1141 (95.7) 1060 (99.7) 1.0 540 (89.7) 438 (95.8) 1.0 
Yes 51 (4.3) 3 (0.3) 15.8 (4.7-63.5) 62 (10.3) 19 (4.2) 2.7 (1.5-4.7) 
*Includes 21 exposed and 2 non-exposed subjects with thyroidectomy scar at time of examination. 
tIncludes subjects with the following thyroid disorders: thyroid cancer (7), thyroid nodules (40), and thyroid cancer plus 
thyroid nodules (4). 
$Excludes 3 subjects with missing data on thyroid disorders. 
§No non-exposed subjects reported thyroid cancer. 
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Table 3. Relative risks (RR) of thyroid nodular disease associated with prior radiotherapy based on clinical examination 
data by radiation dose to the thyroid gland 
Thyroid nodular disease 
Questionaire data* Examination data?, $ 
Yes No RR (95% CI) Yes No RR (95% CI) 
Thyroid dose (cGy) 
0 3 1060 1.0 19 438 1.0 
l-19 4 202 7.0 (1.3-39.6) 11 89 2.9 (1.24.6) 
20-24 13 341 13.5 (3.659.8) :: 168 1.7 (0.7-3.7) 
25-29 23 456 17.8 (5.1-74.9) 216 3.0 (1.65.7) 
30-59 10 133 26.6 (6.7-123.2) 11 62 4.1 (1.7-9.6) 
Excess RR/&y5 0.64 (0.18-2.25) 0.07 (0.03SO). 15) 
*Includes thyroid nodules and thyroid cancer. 
tIncludes 21 exposed and 2 non-exposed subjects with thyroidectomy scar at time of examination. 
IExcludes 5 subjects with missing dosimetry data. 
QExcess RR/&y = (RR - 1)/&y, and is adjusted for year of treatment, gender, and age at treatment; based on the linear 
dose-response-function [text model (2)] and text model (4) 
excess RR per cGy based on models (2) and (4) 
with adjustments for gender, age at treatment 
and year of treatment differed markedly be- 
tween questionnaire data and examination data: 
64% (95% CI = 20-230%) and 7% (95% CI = 
3-20%), respectively. In as much as the examin- 
ation results were assumed to be more reliable, 
additional analyses of these data examined the 
modifying effects of gender, age at treatment, 
religion and number of X-ray treatments on the 
risk of palpable thyroid nodules. 
Efect mod$cation on risk for palpable thyroid 
nodules 
Table 4 presents the RR of thyroid nodularity 
by gender for exposed and non-exposed sub- 
jects. The risk was higher among women 
than men, for both the exposed group 
(RR = 6.3/3.2 = 2.0) and non-exposed group 
(RR = 2.6). The estimated RR due to radiation 
was similar among men (RR = 3.2) and women 
(RR = 6.312.6 = 2.4). Accordingly, the associ- 
ated estimates of excess RR/cGy for men and 
women based on multivariate modeling pro- 
cedures (text-model 3) were 7 and 6%, respec- 
tively (Table 5). 
Analysis of the examination data according 
to religious background (Jewish and other) was 
conducted to evaluate whether Jews are at an 
increased risk of thyroid nodules and are more 
susceptible to radiation-induced nodularity 
(Table 4). Interestingly, the risk was higher 
among Jews than non-Jews for the exposed 
group (RR = 3.8/2.0 = 1.9) but not for the non- 
exposed group (RR = 0.3). Furthermore, the 
estimates of excess RR/cGy for Jews and non- 
Jews were 39 and 5%, respectively (Table 5). It 
should be noted, however, that the exceptionally 
high radiation risk among Jews was related 
more to an exceptionally low risk among the 
non-exposed subjects than to an exceptionally 
elevated risk among the exposed subjects. 
Table 4. Relative risks (RR) of thyroid nodular disease associated with 
prior radiotherapy based on clinical examination data by gender and 
religion for exposed and non-exposed subjects 
Thyroid nodular disease 











7 263 1.0 
12 175 2.6 (0.9-7.4) 
30 349 3.2 (1.3-8.2) 
32 191 6.3 (2.616.0) 
17 341 I.0 
1 68 0.3 (0.0-2.2) 
44 432 2.0 (1.1-3.8) 
13 69 3.8 (l&8.7) 
*Excludes 30 non-exposed subjects with missing data on religion; 1 with 
and 29 without thyroid nodular disease. 
tExcludes 44 exposed subjects with missing data on religion; 5 with and 
39 without thyroid nodules. 
Thyroid Nodularity after Irradiation 
Table 5. Relative risks (RR) of thyroid nodular disease by dose categories for examined subjects by gender, 
age at treatment religion and number of radiation treatments 
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Thyroid dose (cGy) 
Excesst 















































































































*Numbers in parentheses indicate the number of subjects with and without thyroid nodules. 
tExcess RR/cGy = (RR - I)/cGy, is adjusted for year of treatment, gender and age at treatment; based on 
text model (3) with dose continuous. 
$-Value for likelihood ratio test of homogeneity of linear risk parameters. 
5Model includes non-significant main effect for religion; excludes 74 subjects with unknown religion. 
‘RR = 1 for non-exposed subjects. 
The risk of developing thyroid nodules 
among exposed subjects declined with age at 
first X-ray treatment, with subjects under age 4 
years being at highest risk when compared to 
those aged 7-18 years (RR = 2.1, CI = 0.9-5.1). 
Early age at exposure was also associated with 
a much greater excess RR/cGy than exposure at 
later ages (Table 5). 
To assess whether dose fractionation de- 
creases the risk of thyroid nodules, number of 
X-ray treatment sessions (a left-sided and right- 
sided treatment to neck or face given on the 
same day constituted a session) was included in 
model (4). The excess RR of thyroid nodules per 
cGy of exposure for subjects who had less than 
three X-ray treatments was similar to those who 
had three or more treatments (Table 5). 
DISCUSSION 
The present study is the first to evaluate the 
effects of low-dose irradiation on the thyroid 
gland by incorporating all of the following 
design elements: (1) comparison of question- 
naire and clinical examination results, (2) com- 
prehensive dosimetry on individuals and (3) the 
use of a comparison population treated by 
another modality (surgery) for the same condi- 
tion as those exposed to medical irradiation. 
The main conclusions are that questionnaire 
data alone appear to overestimate the impact 
that prior irradiation has on thyroid nodularity, 
and that young age at exposure is a strong 
predictor of future risk. Furthermore, radiation 
risk on a relative scale was similar for men and 
women and possibly higher among Jews. 
The risk of radiation-induced thyroid cancer 
could not be addressed since the percentage of 
thyroid cancers which comprised the thyroid 
nodular disease category was not known. 33% 
of the questionnaire respondents who specifi- 
cally reported a thyroid nodule did not have 
surgery and 80% of the examined subjects 
found to have a palpable thyroid nodule did not 
seek medical attention or did not have surgical 
intervention within 1 year of detection. 
Little is known about the natural history of 
thyroid cancer and thyroid nodules. Papillary 
carcinoma, the most common histologic type of 
thyroid cancer, behaves in a clinically benign 
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fashion more so than the other cell types. It is 
usually slow growing and typically spreads to 
the regional lymph nodes where it may remain 
indolent for many years. It is the primary 
histologic type of thyroid cancer induced by 
radiation. Solitary thyroid nodules are also typ- 
ically slow growing and initially do not disturb 
normal thyroid function [19]. Thyroid nodules 
have also been shown to regress over time [20]. 
The relationship between thyroid nodules and 
thyroid cancer is unclear. Several case- 
control studies have shown that a history of 
thyroid nodules is a risk factor for developing 
thyroid cancer [21,22], and biopsies of thyroid 
nodules in irradiated thyroid glands often reveal 
a high proportion of malignancies [9]. However, 
the progression of a thyroid nodule to cancer 
has not been well-documented [23]. 
Our comparative analysis revealed a disparity 
between prevalence rates of thyroid nodular 
disease calculated from questionnaire and ex- 
amination data. Based on questionnaire data, 
thyroid nodules appeared to be underascer- 
tained among both exposed and non-exposed 
individuals. For the exposed subjects, the ratio 
of the proportion of examined subjects to the 
proportion of questionnaire respondents with 
thyroid nodules was 2.4. For the non-exposed 
subjects, this ratio was 14.0. The greater under- 
ascertainment of thyroid nodules among the 
non-exposed individuals resulted in an almost 
six-fold difference in the relative risk estimates 
between questionnaire and examination data. 
Similarly, there was a nine-fold difference in the 
estimates of the excess RR/cGy between these 
two sources of data. 
Underascertainment of thyroid nodules, in 
general, is not an unexpected finding. Thyroid 
nodules often follow an uneventful course and 
unless symptoms suggestive of thyroid disease 
are present, thyroid examination is usually not 
conducted among young adults. Two possible 
explanations why there was greater underascer- 
tainment among the non-exposed than the ex- 
posed subjects are: (1) exposed subjects who 
were aware of their childhood X-ray treatments 
may have approached their physician for thy- 
roid screening or (2) physicians who knew that 
a subject had a history of head and neck irradi- 
ation were more likely to conduct thyroid ex- 
aminations. Both of these situations could have 
led to greater detection of asymptomatic thyroid 
tumors among the exposed subjects. 
The participation rates in the examination 
component of the study were lower than initially 
anticipated. Nevertheless, our data are consis- 
tent with the results from other studies and 
appear to reflect the “true” prevalence rates of 
thyroid nodular disease for both the non- 
exposed and exposed subjects. Among the non- 
exposed subjects examined in our study, 4.2% 
had a palpable thyroid nodule or a thyroid- 
ectomy scar at examination. This is identical to 
the percentage of thyroid nodules detected in 
the population participating in the Framingham 
Heart Disease Study [23] and among the non- 
exposed comparison group in a previous study 
conducted in Boston on tuberculosis patients 
which used examination procedures similar to 
our study [16]. 
Among the examined exposed subjects, 
10.3% had a palpable thyroid nodule which is 
consistent with palpation results from two recall 
programs of exposed individuals. In the large 
screening program conducted at Michael Reese 
Hospital, Chicago [7] about 13% of the exposed 
subjects had a palpable thyroid nodule. This 
figure increased to 16.5% after the examiner 
reviewed the scintigram and repalpated the sub- 
ject. In an areawide cooperative program of 
thyroid screening conducted in Milwaukee [24], 
10% of the exposed subjects screened in the first 
year were found to have nodules. 
As in any epidemiologic study which relies on 
a subject’s willingness to be examined, there 
exists the potential for self-selection bias. To 
address this issue, we first evaluated participa- 
tion rates by residential area. The majority of 
our study population resided in Massachusetts, 
of whom a similar percentage of exposed and 
non-exposed subjects agreed to be examined. 
For subjects living in the other New England 
states or outside the New England area, a higher 
percentage of eligible exposed than non-exposed 
subjects were examined. The prevalence rates of 
thyroid nodules detected during the examin- 
ation by residential area and exposure status 
were evaluated to determine whether irradiated 
subjects who had convenient access to the clinic 
were more likely to have a palpable thyroid 
nodule than those who lived outside of Massa- 
chusetts. The exposed subjects who traveled 
from outside the New England area had essen- 
tially the same prevalence rate of palpable thy- 
roid nodules as the exposed subjects who came 
from Massachusetts. It is, therefore, unlikely 
that self-selection bias influenced our findings. 
The greater cooperation rates among the ex- 
posed subjects who lived outside of Massachu- 
setts may have been due to their awareness of 
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their radiation history and potential risk for 
thyroid tumors. 
Thyroid disease, in general, typically affects 
females more often than males. It has been 
suggested in several studies of irradiated popu- 
lations that women are also more susceptible 
than men to radiogenic thyroid tumors [1, 3,5]. 
Often there is confusion interpreting this finding 
because the scale upon which these inferences 
are based is not defined. Women have a higher 
risk of developing thyroid nodular disease than 
men, regardless of radiation history, as seen in 
our study. On a relative scale, however, men and 
women appear equally susceptible to radiation- 
induced thyroid nodularity. Because of the 
much higher underlying rate of thyroid disease 
among women, the finding of a similar RR due 
to radiation for men and women implies that 
women have a greater number of excess thyroid 
nodules (and higher absolute risk) than men. 
Age at treatment has been identified as an 
important modifying factor in radiation- 
induced thyroid disease [I, 31. Our findings 
further support this conclusion. The excess risk 
of thyroid nodules/cGy was highest for subjects 
treated under 4 years of age with only a slight 
excess RR/cGy seen for subjects treated after 
age 6. This suggests that the very young thyroid 
gland may be especially sensitive to radiation, 
possibly because of a more active cell prolifer- 
ation capacity. 
Jewish ethnicity has also been suggested as a 
susceptibility factor for radiation-induced thy- 
roid neoplasms [ 1,251. In our study, Jews were 
at a higher radiation risk for thyroid nodularity 
than non-Jews but this increase appeared due, a 
large part, to a peculiar deficit of nodules among 
non-exposed Jews. The reason for this finding is 
unclear but may be related to the small number 
of Jewish subjects in the study. 
The exposed subjects in our study received 
relatively low doses of radiation to their thyroid 
glands and within a limited dose range 
(335.5 cGy; mean 24 cGy). Nevertheless, analysis 
of the risk of thyroid nodular disease by dose 
revealed a statistically significant dose-response 
relationship. The estimate of the percent excess 
RR of thyroid nodules/cGy was 7% for the 
examined subjects. Dose-response relationships 
for thyroid cancer and thyroid adenomas were 
also seen in the Israeli study of children with 
tinea capitis who received low doses of irradi- 
ation (450 cGy) to the thyroid gland, although 
the estimate of excess RR/cGy was higher 
(lo-30%) [3,4]. 
Dose fractionation, measured by number of 
treatment sessions, did not appear to decrease 
the risk of thyroid nodules. Subjects who had 
three or more treatments had a slightly smaller 
excess RR/cGy of thyroid nodules than the 
subjects who had less than three treatments. A 
thorough investigation of the effects of dose 
fractionation on the risk of thyroid nodularity, 
however, could not be made in this study. In 
order to find a fractionation effect, there should 
be comparable total doses for a group of sub- 
jects with and without fractionated treatments. 
In our study, additional fractions (treatments) 
indicated higher total doses thus dose fraction- 
ation could not be adequately assessed. 
The latency period for the development of 
radiation-induced thyroid nodules cannot be 
addressed in this study since the clinical examin- 
ation data were prevalent cases of thyroid nod- 
ules detected at a specific point in time. The time 
period during which the subject was disease free 
could not be established. Nevertheless, radi- 
ation-induced thyroid nodules were detected at 
least 40 years after exposure; 44 years being the 
maximum length of follow-up for exposed ex- 
amined subjects in our study. This is consistent 
with findings from the Michael Reese recall 
program [8] and from the follow-up study of 
thymus-irradiated children [2]. 
In conclusion, the association between low- 
dose X-irradiation for lymphoid hyperplasia 
and the development of thyroid nodules later in 
life was confirmed by both questionnaire and 
thyroid examination data on exposed and non- 
exposed subjects. The magnitude of the associa- 
tion depended on which data source was used. 
The questionnaire data seemed biased in that a 
greater proportion of non-exposed subjects had 
an underascertainment of thyroid nodules. 
We believe that clinical examinations, which 
include a non-exposed comparison group, 
provide the best risk estimates of radiation-in- 
duced thyroid nodular disease since such exam- 
inations are less susceptible to reporting and 
ascertainment biases associated with question- 
naire surveys. 
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